VIVA In Vitro Diagnostics and ASKA Biotech Announce Strategic Partnership to Advance VIVA-ELISA® Industrialization
The Spanish biotechnology company and German CDMO join forces to advance the development and manufacturing of VIVA-ELISA®, targeting its first Research Use Only (RUO) product in Q2 2027. The agreement strengthens VIVA's transition from scientific innovation to industrial execution and reinforces its European biotechnology development roadmap.























